Stay updated with breaking news from Decipher prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veracyte (VCYT) Reports New Data from Phase 3 Trial Further Validating Prognostic Value of Decipher Prostate Genomic Classifier streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Findings presented at the 2023 ASTRO Annual Meeting expand substantial body of evidence demonstrating Decipher Prostate test’s ability to help inform prostate cancer treatment. ....
Veracyte, Inc. (NASDAQ: VCYT) shares are volatile after-hours on Wednesday after the company announced that new data from a phase 3 trial validates the value of the Decipher Prostate Genomic Classifier in assisting physicians make more informed treatment decisions for their ....
Veracyte, Inc. announced that six abstracts highlighting new data from studies evaluating the company’s Decipher Prostate Genomic Classifier and related capabilities will be presented, three as. ....